These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2996346)

  • 1. Infectious complications in heart-lung transplant recipients.
    Brooks RG; Hofflin JM; Jamieson SW; Stinson EB; Remington JS
    Am J Med; 1985 Oct; 79(4):412-22. PubMed ID: 2996346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.
    Dummer JS; White LT; Ho M; Griffith BP; Hardesty RL; Bahnson HT
    J Infect Dis; 1985 Dec; 152(6):1182-91. PubMed ID: 2999255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections in heart-lung transplant recipients.
    Dummer JS; Montero CG; Griffith BP; Hardesty RL; Paradis IL; Ho M
    Transplantation; 1986 Jun; 41(6):725-9. PubMed ID: 3012834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute rejection of the heart-lung allograft and methods of its detection.
    Griffith BP; Durham SJ; Hardesty RL; Trento A; Paradis IL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2527-30. PubMed ID: 3103298
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine in heart and heart-lung transplantation.
    Modry DL; Oyer PE; Jamieson SW; Stinson EB; Baldwin JC; Reitz BA; Dawkins KD; McGregor CG; Hunt SA; Moran M
    Can J Surg; 1985 May; 28(3):274-80, 282. PubMed ID: 3922606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchoscopy in the diagnosis and surveillance of respiratory infections in lung and heart-lung transplant recipients.
    Lehto JT; Koskinen PK; Anttila VJ; Lautenschlager I; Lemström K; Sipponen J; Tukiainen P; Halme M
    Transpl Int; 2005 May; 18(5):562-71. PubMed ID: 15819805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infections in heart and heart and lung transplant recipients.
    Wreghitt TG; Hakim M; Gray JJ; Kucia S; Wallwork J; English TA
    J Clin Pathol; 1988 Jun; 41(6):660-7. PubMed ID: 2838530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated pulmonary rejection after combined heart-lung transplantation.
    McGregor CG; Baldwin JC; Jamieson SW; Billingham ME; Yousem SA; Burke CM; Oyer PE; Stinson EB; Shumway NE
    J Thorac Cardiovasc Surg; 1985 Oct; 90(4):623-6. PubMed ID: 3930886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced infection in cardiac transplant recipients.
    Dresdale AR; Drusin RE; Lamb J; Smith CR; Reemtsma K; Rose EA
    Circulation; 1985 Sep; 72(3 Pt 2):II237-40. PubMed ID: 3896557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in invasive disease due to Candida species following heart and lung transplantation.
    Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
    Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiac rejection in heart and heart-lung transplantation.
    Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
    J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
    Hadley S; Samore MH; Lewis WD; Jenkins RL; Karchmer AW; Hammer SM
    Transplantation; 1995 Mar; 59(6):851-9. PubMed ID: 7535482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart-lung transplantation for irreversible pulmonary hypertension.
    Jamieson SW; Stinson EB; Oyer PE; Reitz BA; Baldwin J; Modry D; Dawkins K; Theodore J; Hunt S; Shumway NE
    Ann Thorac Surg; 1984 Dec; 38(6):554-62. PubMed ID: 6439134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection and reactivation with cytomegalovirus strains in lung transplant recipients.
    Smyth RL; Sinclair J; Scott JP; Gray JJ; Higenbottam TW; Wreghitt TG; Wallwork J; Borysiewicz LK
    Transplantation; 1991 Sep; 52(3):480-2. PubMed ID: 1654605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurological complications of cardiac transplantation.
    Hotson JR; Pedley TA
    Brain; 1976 Dec; 99(4):673-94. PubMed ID: 192413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complications in pulmonary allograft recipients.
    Dauber JH; Paradis IL; Dummer JS
    Clin Chest Med; 1990 Jun; 11(2):291-308. PubMed ID: 2189664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants.
    Penketh AR; Higenbottam TW; Hutter J; Coutts C; Stewart S; Wallwork J
    Thorax; 1988 Oct; 43(10):762-9. PubMed ID: 2849814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2005 Sep; 24(9):1320-6. PubMed ID: 16143251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of cytomegalovirus in heart-lung transplant recipients.
    Hutter JA; Scott J; Wreghitt T; Higenbottam T; Wallwork J
    Chest; 1989 Mar; 95(3):627-31. PubMed ID: 2537711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart and heart-lung transplantation.
    Cabrol C; Gandjbakhch I; Pavie A; Cabrol A; Mattei MF; Leger P; Chomette G; Aupetit B
    Transplant Proc; 1987 Feb; 19(1 Pt 1):88-91. PubMed ID: 3103283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.